Apyx Medical (APYX) Invested Capital (2010 - 2026)

Apyx Medical (APYX) has 17 years of Invested Capital data on file, last reported at $50.3 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 4.54% year-over-year to $50.3 million; the trailing twelve-month figure through Mar 2026 stood at $50.3 million (up 4.54% YoY), and the FY2025 full-year result was $52.0 million, changed 0.4% from the prior year.
• Invested Capital for Q1 2026 stood at $50.3 million, down from $52.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $64.4 million in Q4 2023 and bottomed at $37.9 million in Q4 2022.
• The 5-year median for Invested Capital is $48.1 million (2025), against an average of $48.0 million.
• The widest annual swing landed in 2022, when Invested Capital sank 30.06%; it then surged 69.97% in 2023.
• A 5-year view of Invested Capital shows it stood at $37.9 million in 2022, then soared by 69.97% to $64.4 million in 2023, then dropped by 19.54% to $51.8 million in 2024, then rose by 0.4% to $52.0 million in 2025, then dropped by 3.28% to $50.3 million in 2026.
• The last three Invested Capital figures came in at $50.3 million (Q1 2026), $52.0 million (Q4 2025), and $43.6 million (Q3 2025), per Business Quant data.

Peer Comparison